94 related articles for article (PubMed ID: 12167275)
1. Vascular endothelial growth factor levels in serum do not increase following HIV type 1 and HHV8 seroconversion and lack correlation with AIDS-related Kaposi's sarcoma.
Renwick N; Weverling GJ; Brouwer J; Bakker M; Schulz TF; Goudsmit J
AIDS Res Hum Retroviruses; 2002 Jul; 18(10):695-8. PubMed ID: 12167275
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor (VEGF165) plasma level increase with immunodepression in AIDS patients with Kaposi's sarcoma.
Mercié P; Devianne I; Viallard JF; Faure I; Pellegrin I; Leng B; Dupon M; Barbeau P; Fleury H; Pellegrin JL
Microvasc Res; 1999 Mar; 57(2):208-10. PubMed ID: 10049669
[No Abstract] [Full Text] [Related]
3. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases.
Rezza G; Andreoni M; Dorrucci M; Pezzotti P; Monini P; Zerboni R; Salassa B; Colangeli V; Sarmati L; Nicastri E; Barbanera M; Pristerà R; Aiuti F; Ortona L; Ensoli B
J Natl Cancer Inst; 1999 Sep; 91(17):1468-74. PubMed ID: 10469747
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
[TBL] [Abstract][Full Text] [Related]
5. Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: implications for acquired immunodeficiency syndrome-associated vasculopathy.
Ascherl G; Hohenadl C; Schatz O; Shumay E; Bogner J; Eckhart L; Tschachler E; Monini P; Ensoli B; Stürzl M
Blood; 1999 Jun; 93(12):4232-41. PubMed ID: 10361120
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts.
Samaniego F; Young D; Grimes C; Prospero V; Christofidou-Solomidou M; DeLisser HM; Prakash O; Sahin AA; Wang S
Cell Growth Differ; 2002 Aug; 13(8):387-95. PubMed ID: 12193477
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma and human herpesvirus 8 infection do not protect HIV-1 infected homosexual men from AIDS dementia complex.
Renwick N; Weverling GJ; Halaby T; Portegies P; Bakker M; Schulz TF; Goudsmit J
AIDS; 2001 Nov; 15(16):2165-9. PubMed ID: 11684936
[TBL] [Abstract][Full Text] [Related]
8. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B
J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519
[TBL] [Abstract][Full Text] [Related]
10. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
[TBL] [Abstract][Full Text] [Related]
11. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis.
Polstra AM; Cornelissen M; Goudsmit J; van der Kuyl AC
J Med Virol; 2004 Nov; 74(3):390-6. PubMed ID: 15368522
[TBL] [Abstract][Full Text] [Related]
12. Involvement of vascular endothelial growth factor in Kaposi's sarcoma associated with acquired immunodeficiency syndrome.
Sakurada S; Kato T; Mashiba K; Mori S; Okamoto T
Jpn J Cancer Res; 1996 Nov; 87(11):1143-52. PubMed ID: 9045943
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
[TBL] [Abstract][Full Text] [Related]
14. Comparison of constitutive cytokine release in high and low histologic grade AIDS-related Kaposi's sarcoma cell strains and in sera from HIV+/KS+ and HIV+/KS- patients.
Bailer RT; Lazo A; Ng-Bautista CL; Hout BL; Ness GM; Hegtvedt AK; Blakeslee JR; Stephens RE; Brierley GP; Mallery SR
J Interferon Cytokine Res; 1995 May; 15(5):473-83. PubMed ID: 7648450
[TBL] [Abstract][Full Text] [Related]
15. Soluble biomarkers of HIV-1-related systemic immune activation are associated with high plasma levels of growth factors implicated in the pathogenesis of Kaposi sarcoma in adults.
Nana BC; Esemu LF; Besong ME; Atchombat DHN; Ogai K; Sobgui TMP; Nana CMM; Seumko'o RMN; Awanakan H; Ekali GL; Leke RGF; Okamoto S; Ndhlovu LC; Megnekou R
Front Immunol; 2023; 14():1216480. PubMed ID: 37809059
[TBL] [Abstract][Full Text] [Related]
16. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study.
Cianfrocca M; Cooley TP; Lee JY; Rudek MA; Scadden DT; Ratner L; Pluda JM; Figg WD; Krown SE; Dezube BJ
J Clin Oncol; 2002 Jan; 20(1):153-9. PubMed ID: 11773164
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 6 and AIDS-associated Kaposi's sarcoma: a nested case control study within the Multicenter AIDS Cohort Study.
Dourado I; Martínez-Maza O; Kishimoto T; Suzuki H; Detels R
AIDS Res Hum Retroviruses; 1997 Jun; 13(9):781-8. PubMed ID: 9171222
[TBL] [Abstract][Full Text] [Related]
19. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma.
Sirianni MC; Vincenzi L; Topino S; Giovannetti A; Mazzetta F; Libi F; Scaramuzzi D; Andreoni M; Pinter E; Baccarini S; Rezza G; Monini P; Ensoli B
Eur J Immunol; 2002 Oct; 32(10):2711-20. PubMed ID: 12355422
[TBL] [Abstract][Full Text] [Related]
20. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science.
Dezube BJ; Sullivan R; Koon HB
J Cell Physiol; 2006 Dec; 209(3):659-62. PubMed ID: 17001705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
